BioCentury
ARTICLE | Distillery Therapeutics

Cancer

April 18, 2017 2:22 PM UTC

Patient sample, cell culture, and mouse studies suggest inhibiting BCL6 could help treat glioblastoma multiforme (GBM). In patients, high tumor levels of BCL6 were associated with poor survival. In GB...

BCIQ Company Profiles

Cedars-Sinai Medical Center

BCIQ Target Profiles

B cell CLL lymphoma 6 (BCL6)